Psychedelics for Alzheimer’s Disease Palliative Care (McManus et al.)

Published: Aug 18, 2022
Advances in Psychiatry and Behavioral Health

~

(Patent Highlight) Restoration of Motor Function Post-Neurological Injury Using Serotonergic Agonist (Kargbo)

Published: Aug 22, 2022
ACS Medicinal Chemistry Letters

~

(Patent Highlight) Application of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders (Kargbo)

Published: Aug 22, 2022
ACS Medicinal Chemistry Letters

~

Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative (Devenot et al.)

Published: Aug 22, 2022
Anthropology of Consciousness

~

Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test? (Molumby et al.)

Published: Aug 18, 2022
Journal of Humanistic Psychology

~

The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness (Longo)

Published: Aug 19, 2022
Journal of Psychoactive Drugs

~

(Preproof) Psychedelics as potent anti-inflammatory therapeutics (Nichols)

Available Online: Aug 22, 2022
Neuropharmacology

Psychedelic Science Updates (@UpdatesPsy)
Psychedelic Science Updates (@UpdatesPsy)

Written by Psychedelic Science Updates (@UpdatesPsy)

Updates on the latest peer-reviewed & preprint psychedelic research and clinical trials. Twitter handle @UpdatesPsy or @UpdatesPsy@mastodon.social on Mastodon.

No responses yet